Consensus on the tertiary prevention of primary liver cancer

Yuemin Nan; Xiaoyuan Xu; Shiming Dong; Ming Yang; Ling Li; Suxian Zhao; Zhongping Duan; Jidong Jia; Lai Wei; Hui Zhuang; Chinese Society of Hepatology, Chinese Medical Association

doi:10.1007/s12072-023-10549-2

Consensus on the tertiary prevention of primary liver cancer

Hepatol Int. 2023 Oct;17(5):1057-1071. doi: 10.1007/s12072-023-10549-2. Epub 2023 Jun 27.

Authors

Collaborators

Chinese Society of Hepatology, Chinese Medical Association:
Hongsong Chen, Huiguo Ding, Zhongping Duan, Jian-Gao Fan, Yanhang Gao, He-Ping Hu, Jianrong Huang, Jun Li, Wencong Li, Wen-Gang Li, Jingfeng Liu, Lingdi Liu, Yuemin Nan, Wanhua Ren, Jia Shang, Maorong Wang, Wen Xie, Mengsu Zeng, Yuguo Zhang, Jingmin Zhao, Shousong Zhao, Weifeng Zhao, Jian Zhou

Affiliations

¹ Department of Traditional and Western Medical Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China. nanyuemin@hebmu.edu.cn.
² Department of Infectious Diseases, Peking University First Hospital, Beijing, 100034, China. xiaoyuanxu@bjmu.edu.cn.
³ Department of Traditional and Western Medical Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.
⁴ Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.
⁵ Department of Intervention, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China.
⁶ Artificial Liver Centre, Beijing You-An Hospital, Capital Medical University, Beijing, 100069, China.
⁷ Liver Research Centre, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
⁸ Hepatopancreatobiliary Centre, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, 102218, China.
⁹ Department of Microbiology and Centre for Infectious Diseases, Peking University Health Science Centre, Beijing, 100191, China.

Abstract

To effectively prevent recurrence, improve the prognosis and increase the survival rate of primary liver cancer (PLC) patients with radical cure, the Chinese Society of Hepatology, Chinese Medical Association, invited clinical experts and methodologists to develop the Consensus on the Tertiary Prevention of Primary Liver Cancer, which was based on the clinical and scientific advances on the risk factors, histopathology, imaging finding, clinical manifestation, and prevention of recurrence of PLC. The purpose is to provide a current basis for the prevention, surveillance, early detection and diagnosis, and the effective measures of PLC recurrence.

Keywords: Curative treatment; Detection; Diagnosis; Hepatocellular carcinoma; Metastasis; Recurrence; Risk stratification; Surveillance; Survival; Tertiary prevention.

MeSH terms

Carcinoma, Hepatocellular* / diagnosis
Carcinoma, Hepatocellular* / prevention & control
Consensus
Humans
Liver Neoplasms* / diagnosis
Liver Neoplasms* / prevention & control
Prognosis
Tertiary Prevention